Xiaofei Yang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Mesenchymal stem cell research
Papers in
-
- Pluripotent Stem Cells Research 6
- RNA Research and Splicing 4
- Circular RNAs in diseases 3
- RNA modifications and cancer 3
- Surgery 16
- Pancreatic function and diabetes 7
- Co-authors
- Furong Li (11 shared papers)Furong Li (8 shared papers)Lijuan Shao (3 shared papers)Wei Yang (6 shared papers)Dawei Wang (2 shared papers)Haitao Luo (5 shared papers)Irfan Ahmad Ansari (1 shared paper)Yaoyu Feng (1 shared paper)
- Journals
- Stem Cell Research & Therapy (4 papers)Cell Death Discovery (1 paper)Journal of Physiology and Biochemistry (1 paper)Phytotherapy Research (1 paper)Stem Cell Research (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Xiaofei Yang
37 papers receiving 337 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 79
- Genetics 30
- Complementary and alternative medicine 23
- Molecular Biology 178
- Immunology 41
Countries citing papers authored by Xiaofei Yang
This map shows the geographic impact of Xiaofei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Yang more than expected).
Fields of papers citing papers by Xiaofei Yang
This network shows the impact of papers produced by Xiaofei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Yang. The network helps show where Xiaofei Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofei Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 37 | |
| 2 | 2021 | 29 | |
| 3 | 2017 | 26 | |
| 4 | 2021 | 26 | |
| 5 | 2018 | 24 | |
| 6 | 2017 | 18 | |
| 7 | 2021 | 16 | |
| 8 | 2021 | 14 | |
| 9 | 2017 | 12 | |
| 10 | 2021 | 11 | |
| 11 | 2020 | 11 | |
| 12 | 2022 | 10 | |
| 13 | 2014 | 9 | |
| 14 | 2022 | 9 | |
| 15 | 2020 | 9 | |
| 16 | 2014 | 9 | |
| 17 | 2020 | 8 | |
| 18 | Direct reprogramming of hepatocytes into insulin-producing cells for anti-diabetic treatment by ultrasound-targeted microbubble destruction enhanced hydrodynamic gene delivery. | 2020 | 7 |
| 19 | 2014 | 6 | |
| 20 | 2020 | 6 |
About Xiaofei Yang
Xiaofei Yang is a scholar working on Molecular Biology, Surgery, Cancer Research, Oncology and Immunology, having authored 37 papers that have together received 345 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (7 papers), Pluripotent Stem Cells Research (6 papers), Cancer-related molecular mechanisms research (5 papers), RNA Research and Splicing (4 papers), Circular RNAs in diseases (3 papers), RNA modifications and cancer (3 papers), Mesenchymal stem cell research (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). The work is most often cited by research in Cancer Research (79 citations), Genetics (30 citations), Complementary and alternative medicine (23 citations), Molecular Biology (178 citations) and Immunology (41 citations). Xiaofei Yang has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Furong Li, Furong Li, Lijuan Shao, Wei Yang, Dawei Wang, Haitao Luo, Irfan Ahmad Ansari, Yaoyu Feng, M. Salman Khan and Hui Qi. Their work appears in journals such as Stem Cell Research & Therapy, Cell Death Discovery, Journal of Physiology and Biochemistry, Phytotherapy Research and Stem Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.